Galera Therapeutics Files 8-K Report
Ticker: GRTX · Form: 8-K · Filed: 2026-04-03T06:03:35-04:00
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Galera Therapeutics filed an 8-K, but no juicy details yet.
AI Summary
On April 3, 2026, Galera Therapeutics, Inc. filed an 8-K report detailing other events. The filing does not contain specific financial figures or significant business updates beyond the reporting of the event itself.
Why It Matters
This filing indicates a corporate event has occurred for Galera Therapeutics, Inc., requiring disclosure to the public.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report of other events and does not contain information that inherently increases risk.
Key Players & Entities
- Galera Therapeutics, Inc. (company) — Filer of the 8-K report
- 0001563577 (company) — CIK number for Galera Therapeutics, Inc.
- 2026-04-03 (date) — Filing date and period of report
FAQ
What type of event is reported in this 8-K filing?
This 8-K filing reports under Item 8.01, which pertains to 'Other Events'.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 3, 2026.
What is the CIK number for Galera Therapeutics, Inc.?
The CIK number for Galera Therapeutics, Inc. is 0001563577.
What is the business address of Galera Therapeutics, Inc.?
The business address is 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355.
What is the SIC code for Galera Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001193125-26-141187 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-141187 Filing Date 2026-04-03 Accepted 2026-04-03 06:03:35 Documents 11 Period of Report 2026-04-03 Items Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d117348d8k.htm iXBRL 8-K 24429 Complete submission text file 0001193125-26-141187.txt 137221 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA grtx-20260403.xsd EX-101.SCH 2510 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20260403_lab.xml EX-101.LAB 17955 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20260403_pre.xml EX-101.PRE 11237 15 EXTRACTED XBRL INSTANCE DOCUMENT d117348d8k_htm.xml XML 3764 Mailing Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 Business Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 610-725-1500 Galera Therapeutics, Inc. (Filer) CIK : 0001563577 (see all company filings) EIN. : 461454898 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 26836710 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)